Wells Fargo & Company BRIDGEBIO PHARMA INC Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024
Number of Shares
15,111,000
Previous 10,697,000 41.26%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
N/A
4,414,000 Added 41.26%
15,111,000 $0
Q3 2024

Nov 13, 2024
BUY
N/A
37,000 Added 0.35%
10,697,000 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-1,712,000 Reduced 13.84%
10,660,000 $0
Q1 2024

May 10, 2024
SELL
N/A
-4,245,000 Reduced 25.55%
12,372,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
56,000 Added 0.34%
16,617,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
7,734,000 Added 87.62%
16,561,000 $0
Q2 2023

Aug 15, 2023
BUY
N/A
300,000 Added 3.52%
8,827,000 $0
Q1 2023

May 12, 2023
SELL
N/A
-2,000,000 Reduced 19.0%
8,527,000 $0
Q2 2022

Aug 12, 2022
BUY
N/A
1,000,000 Added 10.5%
10,527,000 $4.26 Million
Q1 2022

May 16, 2022
BUY
N/A
9,527,000 New
9,527,000 $4.53 Million
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email